2. Search Result
Search Result
Results for "

parenteral

" in MedChemExpress (MCE) Product Catalog:

50

Inhibitors & Agonists

6

Biochemical Assay Reagents

1

Peptides

7

Natural
Products

1

Isotope-Labeled Compounds

1

Click Chemistry

2

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0187A
    Doripenem monohydrate
    5+ Cited Publications

    S 4661 monohydrate

    		 Bacterial Antibiotic Infection
    Doripenem (S 4661) monohydrate, a 1β-methyl parenteral carbapenem, has very broad-spectrum activity against Gram-positive and Gram-negative aerobic bacteria .
    Doripenem monohydrate
  • HY-B0187
    Doripenem
    5+ Cited Publications

    S 4661

    		 Bacterial Antibiotic Infection
    Doripenem (S 4661), a 1β-methyl parenteral carbapenem, has very broad-spectrum activity against Gram-positive and Gram-negative aerobic bacteria .
    Doripenem
  • HY-A0285
    Norethisterone enanthate

    Norigest

    		 Progesterone Receptor Endocrinology
    Norethisterone enanthate is a long-acting parenteral progestogen. Norethisterone enanthate is orally active . Norethisterone enanthate is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    Norethisterone enanthate
  • HY-P2072
    GF109

    		Angiotensin-converting Enzyme (ACE) Cardiovascular Disease
    GF109 is a potent parenteral inhibitor of angiotensin converting enzyme (ACE). GF109 has antihypertensive effects .
    GF109
  • HY-B0187AR
    Doripenem (monohydrate) (Standard)

    		Bacterial Antibiotic Infection
    Doripenem (monohydrate) (Standard) is the analytical standard of Doripenem (monohydrate). This product is intended for research and analytical applications. Doripenem (S 4661) monohydrate, a 1β-methyl parenteral carbapenem, has very broad-spectrum activity against Gram-positive and Gram-negative aerobic bacteria .
    Doripenem (monohydrate) (Standard)
  • HY-123022
    Tomopenem

    CS-023; RO4908463; R-115685

    		 Bacterial Infection
    Tomopenem (CS-023; RO4908463; R-115685) is a longer-half-life parenteral carbapenem. Tomopenem shows broad activity against 63 reference species. The activity of tomopenem against 293 clinical isolates is potent (MIC90, 0.06 to 4 μg/mL). Antianaerobic activity .
    Tomopenem
  • HY-166999
    m-PEG-Vinylsulfone (MW 20000)

    m-PEG-VS (MW 20000)

    		 Biochemical Assay Reagents Others
    m-PEG-Vinylsulfone (MW 20000) (m-PEG-VS (MW 20000)) is a PEG derivative that modulates the release of drugs from microparticle systems for parenteral administration. m-PEG-Vinylsulfone (MW 20000) can be used in drug delivery studies .
    m-PEG-Vinylsulfone (MW 20000)
  • HY-167000
    m-PEG-Vinylsulfone (MW 10000)

    m-PEG-VS (MW 10000)

    		 Biochemical Assay Reagents Others
    m-PEG-Vinylsulfone (MW 10000) (m-PEG-VS (MW 10000)) is a PEG derivative that modulates the release of drugs from microparticle systems for parenteral administration. m-PEG-Vinylsulfone (MW 10000) can be used in drug delivery studies .
    m-PEG-Vinylsulfone (MW 10000)
  • HY-166995
    Bis-Vinylsulfone-PEG (MW 5000)

    Bis-VS-PEG (MW 5000)

    		 Biochemical Assay Reagents Others
    Bis-Vinylsulfone-PEG (MW 5000) (Bis-VS-PEG (MW 5000)) is a PEG derivative that modulates the release of drugs from microparticle systems for parenteral administration. Bis-Vinylsulfone-PEG (MW 5000) can be used in drug delivery studies .
    Bis-Vinylsulfone-PEG (MW 5000)
  • HY-166998
    m-PEG-Vinylsulfone (MW 5000)

    m-PEG-VS (MW 5000)

    		 Biochemical Assay Reagents Others
    m-PEG-Vinylsulfone (MW 5000) (m-PEG-VS (MW 5000)) is a PEG derivative that modulates the release of drugs from microparticle systems for parenteral administration. m-PEG-Vinylsulfone (MW 5000) can be used in drug delivery studies .
    m-PEG-Vinylsulfone (MW 5000)
  • HY-166993
    Cy5-PEG-methyltetrazine (MW 5000)

    		Biochemical Assay Reagents Others
    Cy5-PEG-methyltetrazine (MW 5000) is a PEG derivative that modulates the release of drugs from microparticle systems for parenteral administration. Cy5-PEG-methyltetrazine (MW 5000) can be used in drug delivery studies .
    Cy5-PEG-methyltetrazine (MW 5000)
  • HY-A0285R
    Norethisterone enanthate (Standard)

    		Progesterone Receptor Endocrinology
    Norethisterone enanthate (Standard) is the analytical standard of Norethisterone enanthate. This product is intended for research and analytical applications. Norethisterone enanthate is a long-acting parenteral progestogen. Norethisterone enanthate is orally active . Norethisterone enanthate is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    Norethisterone enanthate (Standard)
  • HY-117736
    Ro 09-1428

    		Penicillin-binding protein (PBP) Bacterial Infection Inflammation/Immunology
    Ro 09-1428 is a broad-spectrum parenteral cephalosporin. Ro 09-1428 has potent antibacterial activities against Pseudomonas aeruginosa and Acinetobacter caloaceticus, with MIC90s of 0.39 and 6.25 μg/mL, respectively, better than Ceftazidime (HY-B0593). Additionally, Ro 09-1428 shows high activity against Escherichia coli, Kkbsielia pneumoniae, Proteus mirabilis, P. aeruginosa, staphylococci, and more. Ro 09-1428 preferentially attacks PBP 3 for target in E. coli and P. aeruginosa, which is promising for research of septicemias and serious P. aeruginosa infections .
    Ro 09-1428
  • HY-13573
    Biapenem
    4 Publications Verification

    CLI 86815; L 627; LJC 10627

    		 Beta-lactamase Bacterial Antibiotic Infection
    Biapenem (CLI 86815; L 627; LJC 10627) a parenteral carbapenem antibacterial agent with a broad spectrum.
    Biapenem
  • HY-106574
    Ceftobiprole medocaril

    BAL5788

    		 Bacterial Infection Inflammation/Immunology
    Ceftobiprole medocaril (BAL5788) is the parenteral proagent of Ceftobiprole (HY-112579). Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens .
    Ceftobiprole medocaril
  • HY-106574A
    Ceftobiprole medocaril sodium

    BAL5788 sodium

    		 Bacterial Infection Inflammation/Immunology
    Ceftobiprole medocaril (BAL5788) sodium is the parenteral proagent of Ceftobiprole (HY-112579). Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens .
    Ceftobiprole medocaril sodium
  • HY-117824
    L-703014

    		Integrin Others
    L-703014 is a fibrinogen receptor antagonist, with the IC50 of 94 nM, that acts as a novel parenteral and potential oral antithrombotic agent .
    L-703014
  • HY-B0734
    Cefotiam

    SCE-963; Cefotiam Dihydrochloride

    		 Antibiotic Bacterial Infection
    Cefotiam (SCE-963) is a parenteral cephalosporin antibiotic. Cefotiam has broad-spectrum activity against Gram-positive and Gram-negative bacteria .
    Cefotiam
  • HY-B0734A
    Cefotiam hydrochloride

    SCE-963 hydrochloride

    		 Antibiotic Bacterial Infection
    Cefotiam (SCE-963) hydrochloride is a parenteral cephalosporin antibiotic. Cefotiam hydrochloride has broad-spectrum activity against Gram-positive and Gram-negative bacteria .
    Cefotiam hydrochloride
  • HY-B0734B
    Cefotiam dihydrochloride hydrate

    SCE-963 dihydrochloride hydrate

    		 Antibiotic Bacterial Infection
    Cefotiam (SCE-963) dihydrochloride hydrate is a parenteral cephalosporin antibiotic. Cefotiam dihydrochloride hydrate has broad-spectrum activity against Gram-positive and Gram-negative bacteria .
    Cefotiam dihydrochloride hydrate
  • HY-13573R
    Biapenem (Standard)

    		Beta-lactamase Bacterial Antibiotic Infection
    Biapenem (Standard) is the analytical standard of Biapenem. This product is intended for research and analytical applications. Biapenem (CLI 86815; L 627; LJC 10627) a parenteral carbapenem antibacterial agent with a broad spectrum.
    Biapenem (Standard)
  • HY-B0441A
    Tobramycin sulfate
    5+ Cited Publications

    Nebramycin Factor 6 sulfate; Deoxykanamycin B sulfate

    		 Bacterial Antibiotic Infection Cancer
    Tobramycin sulfate (Nebramycin Factor 6 sulfate) is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms .
    Tobramycin sulfate
  • HY-108903
    Hyaluronidase (human recombinant)
    5+ Cited Publications

    Hylenex; Vorhyaluronidase alfa; rHuPH 20

    		 Biochemical Assay Reagents Glycosidase Metabolic Disease
    Hyaluronidase (human recombinant) (Hylenex; Vorhyaluronidase alfa; rHuPH 20) is an enzyme that catalyzes the degradation of hyaluronic acid. Hyaluronidase (human recombinant) is used to improve the absorption and dispersal of parenteral fluids, medications, and contrast media .
    Hyaluronidase (human recombinant)
  • HY-B0771
    Cefozopran

    SCE-2787

    		 Bacterial Antibiotic Infection
    Cefozopran (SCE-2787) is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran, an antibiotic, has a broad spectrum of antibacterial activity, inhibiting most of the gram-negative and gram-positive organisms .
    Cefozopran
  • HY-B0771A
    Cefozopran hydrochloride

    SCE-2787 hydrochloride

    		 Bacterial Antibiotic Infection
    Cefozopran (SCE-2787) hydrochloride is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran hydrochloride, an antibiotic, has a broad spectrum of antibacterial activity, inhibiting most of the gram-negative and gram-positive organisms .
    Cefozopran hydrochloride
  • HY-153836
    Anivamersen

    		Factor Xa Others
    Anivamersen is an RNA aptamer to reverse the anticoagulant effect of the parenteral factor IXa inhibitor pegnivacogin. REG1 is a novel anticoagulation system consisting of pegnivacogin, an RNA aptamer inhibitor of coagulation factor IXa, and anivamersen, a complementary sequence reversal oligonucleotide.
    Anivamersen
  • HY-153836A
    Anivamersen sodium

    		Factor Xa Others
    Anivamersen sodium is an RNA aptamer to reverse the anticoagulant effect of the parenteral factor IXa inhibitor pegnivacogin. REG1 is a novel anticoagulation system consisting of pegnivacogin, an RNA aptamer inhibitor of coagulation factor IXa, and anivamersen, a complementary sequence reversal oligonucleotide.
    Anivamersen sodium
  • HY-16035
    Alatrofloxacin

    		DNA/RNA Synthesis Antibiotic Cancer
    Alatrofloxacin, the parenteral proagent of Trovafloxacin, is a fluoronaphthyridone which contains an L-alanyl-L-alanyl salt. Alatrofloxacin functions similar to other fluoroquinolone antibiotics in that it not only has antibiotic activity to kill invading organisms by interfering with DNA synthesis, it possesses immunosuppressive activity .
    Alatrofloxacin
  • HY-137158
    16-Phenoxy tetranor Prostaglandin E2

    16-Phenoxy tetranor PGE2

    		 Prostaglandin Receptor Metabolic Disease
    16-phenoxy tetranor PGE2 is the free acid form of sulprostone formed by the hydrolysis of the methylsulfonamide bond.1 16-phenoxy tetranor PGE2 is a minor metabolite of sulprostone found in human plasma after parenteral administration of the drug.
    16-Phenoxy tetranor Prostaglandin E2
  • HY-B0441
    Tobramycin
    5+ Cited Publications

    Nebramycin Factor 6; Deoxykanamycin B

    		 Bacterial Antibiotic Infection Cancer
    Tobramycin (Nebramycin Factor 6) is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms .Tobramycin can be used to pneumonia research caused by Pseudomonas aeruginosa .
    Tobramycin
  • HY-129683
    AM3102

    		PPAR Metabolic Disease
    AM3102 is an oleoylethanolamide (OEA) analog. AM3102 is an endogenous high-affinity PPAR-alpha agonist. AM3102 resists enzymatic hydrolysis, activates PPAR-alpha with high potency in vitro, and persistently reduces feeding when administered in vivo either parenterally or orally .
    AM3102
  • HY-B2203
    Monocalcium glycerophosphate

    		Phosphatase Metabolic Disease
    Monocalcium glycerophosphate is an inhibitor of intestinal alkaline phosphatase F3, and it has anti-cavity properties. Monocalcium glycerophosphate is a source of calcium and phosphorus in total parenteral nutrition solutions, helps prevent the mineralization and development of bones from intravenous nutrition, and maintains the integrity of the intestinal epithelium .
    Monocalcium glycerophosphate
  • HY-B0771AR
    Cefozopran (hydrochloride) (Standard)

    		Bacterial Antibiotic Infection
    Cefozopran (hydrochloride) (Standard) is the analytical standard of Cefozopran (hydrochloride). This product is intended for research and analytical applications. Cefozopran (SCE-2787) hydrochloride is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran hydrochloride, an antibiotic, has a broad spectrum of antibacterial activity, inhibiting most of the gram-negative and gram-positive organisms .
    Cefozopran (hydrochloride) (Standard)
  • HY-105284
    Sulopenem
    1 Publications Verification

    CP-70429

    		 Beta-lactamase Bacterial Antibiotic Infection
    Sulopenem (CP-70429) is an orally active, parenteral penem antibiotic with broad-spectrum activities against Gram-positive and Gram-negative bacteria. Sulopenem has the potential for urinary tract infections and intra-abdominal infections treatment. Sulopenem is inactive against Pseudomonas aeruginosa and Xanthomonas maltophilia .
    Sulopenem
  • HY-145427
    NU5455

    		DNA-PK Cancer
    NU5455 is a potent, selective, and orally active inhibitor of DNA-PKcs. NU5455 administration increases both the efficacy and the toxicity of a parenterally administered topoisomerase inhibitor. NU5455 enhances the activity of Doxorubicin released locally in liver tumor xenografts without inducing any adverse effect .
    NU5455
  • HY-105284A
    Sulopenem sodium

    CP-70429 sodium

    		 Bacterial Antibiotic Inflammation/Immunology
    Sulopenem (sodium)(CP-70429 (sodium)) is an orally active, parenteral penem antibiotic with broad-spectrum activities against Gram-positive and Gram-negative bacteria. Sulopenem has the potential for urinary tract infections and intra-abdominal infections treatment. Sulopenem is inactive against Pseudomonas aeruginosa and Xanthomonas maltophilia .
    Sulopenem sodium
  • HY-125643R
    Pitavastatin lactone (Standard)

    		Drug Metabolite Cardiovascular Disease
    Tobramycin (Standard) is the analytical standard of Tobramycin. This product is intended for research and analytical applications. Tobramycin (Nebramycin Factor 6) is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms .Tobramycin can be used to pneumonia research caused by Pseudomonas aeruginosa .
    Pitavastatin lactone (Standard)
  • HY-B0441R
    Tobramycin (Standard)

    		Bacterial Antibiotic Infection Cancer
    Tobramycin (Standard) is the analytical standard of Tobramycin. This product is intended for research and analytical applications. Tobramycin (Nebramycin Factor 6) is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms .Tobramycin can be used to pneumonia research caused by Pseudomonas aeruginosa .
    Tobramycin (Standard)
  • HY-W071746
    Linolelaidic acid
    1 Publications Verification

    Linoelaidic acid

    		 Endogenous Metabolite Parasite Apoptosis Infection Inflammation/Immunology
    Linolelaidic acid (Linoelaidic acid) is an omega-6 trans fatty acid (TFA) that is an essential nutrient with oral activity. Linolelaidic acid can be added to enteral nutrition (oral), parenteral nutrition (intravenous), and infant formula. Linolelaidic acid has anti-inflammatory and anti-parasitic ((Parasite)) activities, and can induce Apoptosis. Linolelaidic acid is useful for research in infections .
    Linolelaidic acid
  • HY-107329R
    Cefathiamidine (Standard)

    		Bacterial Antibiotic Infection
    Cefathiamidine (Standard)
  • HY-107329
    Cefathiamidine

    		Bacterial Antibiotic Infection
    Cefathiamidine is a first-generation cephalosporin antibacterial agent and is used to treat infections caused by susceptible bacteria. Cefathiamidine exhibits a wide spectrum of antimicrobial activity against bacteria. Cefathiamidine is used for the treatment of respiratory, liver, five senses, urinary tract infections, endocarditis and sepsis .
    Cefathiamidine
  • HY-W017241R
    1-Naphthalenemethanol (Standard)

    		Bacterial Infection Inflammation/Immunology
    Norethisterone enanthate (Standard) is the analytical standard of Norethisterone enanthate. This product is intended for research and analytical applications. Norethisterone enanthate is a long-acting parenteral progestogen. Norethisterone enanthate is orally active . Norethisterone enanthate is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    1-Naphthalenemethanol (Standard)
  • HY-W339484
    1-Ethyl-2-methyl-3-hydroxypyrid-4-one

    		Biochemical Assay Reagents Others
    1-Ethyl-2-methyl-3-hydroxypyrid-4-one is an α-ketohydroxypyridinium iron chelator with high specificity for iron and no specific activity against other metal ions such as copper, zinc, calcium and magnesium. In rabbits with iron overload, 1-Ethyl-2-methyl-3-hydroxypyrid-4-one increased iron excretion after oral or parenteral administration.
    1-Ethyl-2-methyl-3-hydroxypyrid-4-one
  • HY-13678A
    Meropenem trihydrate
    Maximum Cited Publications
    15 Publications Verification

    SM 7338 trihydrate

    		 Penicillin-binding protein (PBP) Bacterial Antibiotic Infection Cancer
    Meropenem trihydrate (SM 7338 trihydrate) is a carbapenem antibiotic with broad-spectrum antibacterial activity. Meropenem trihydrate has activity against susceptible and resistant N. gonorrhoeae (MIC value of 0.02-0.06 mg/mL), H. influenzae (MIC value of 0.03-0.12 mg/mL), and H. ducreyi (MIC value of 0.015-0.12 mg/mL) .
    Meropenem trihydrate
  • HY-13678S1
    Meropenem-d6-1

    SM 7338-d6-1

    		 Bacterial Antibiotic Infection
    Meropenem-d6-1 (SM 7338-d6-1) is the deuterium labeled Meropenem. Meropenem (SM 7338) is a carbapenem antibiotic with broad-spectrum antibacterial activity. Meropenem has activity against susceptible and resistant N. gonorrhoeae (MIC value of 0.02-0.06 mg/mL), H. influenzae (MIC value of 0.03-0.12 mg/mL), and H. ducreyi (MIC value of 0.015-0.12 mg/mL) .
    Meropenem-d6-1
  • HY-13678
    Meropenem
    Maximum Cited Publications
    15 Publications Verification

    SM 7338

    		 Penicillin-binding protein (PBP) Bacterial Antibiotic Infection Cancer
    Meropenem (SM 7338) is a carbapenem antibiotic with broad-spectrum antibacterial activity. Meropenem has activity against susceptible and resistant N. gonorrhoeae (MIC value of 0.02-0.06 mg/mL), H. influenzae (MIC value of 0.03-0.12 mg/mL), and H. ducreyi (MIC value of 0.015-0.12 mg/mL) .
    Meropenem
  • HY-13678R
    Meropenem (Standard)

    		Penicillin-binding protein (PBP) Bacterial Antibiotic Infection Cancer
    Meropenem (Standard) is the analytical standard of Meropenem. This product is intended for research and analytical applications. Meropenem (SM 7338) is a carbapenem antibiotic with broad-spectrum antibacterial activity. Meropenem has activity against susceptible and resistant N. gonorrhoeae (MIC value of 0.02-0.06 mg/mL), H. influenzae (MIC value of 0.03-0.12 mg/mL), and H. ducreyi (MIC value of 0.015-0.12 mg/mL) .
    Meropenem (Standard)
  • HY-13678AR
    Meropenem (trihydrate) (Standard)

    		Penicillin-binding protein (PBP) Bacterial Antibiotic Infection Cancer
    Meropenem (trihydrate) (Standard) is the analytical standard of Meropenem (trihydrate). This product is intended for research and analytical applications. Meropenem trihydrate (SM 7338 trihydrate) is a carbapenem antibiotic with broad-spectrum antibacterial activity. Meropenem trihydrate has activity against susceptible and resistant N. gonorrhoeae (MIC value of 0.02-0.06 mg/mL), H. influenzae (MIC value of 0.03-0.12 mg/mL), and H. ducreyi (MIC value of 0.015-0.12 mg/mL) .
    Meropenem (trihydrate) (Standard)
  • HY-W740053
    Meropenem sodium

    		Penicillin-binding protein (PBP) Bacterial Antibiotic Infection Cancer
    Meropenem sodium is a carbapenem antibiotic with broad-spectrum antibacterial activity. Meropenem sodium has activity against susceptible and resistant N. gonorrhoeae (MIC value of 0.02-0.06 mg/mL), H. influenzae (MIC value of 0.03-0.12 mg/mL), and H. ducreyi (MIC value of 0.015-0.12 mg/mL) .
    Meropenem sodium
  • HY-145504
    12-Dipalmitoyl-3-Linoelaidoyl-rac-glycerol

    1,2-Palmitin-3-Linoelaidin

    		 Biochemical Assay Reagents Metabolic Disease
    12-Dipalmitoyl-3-Linoelaidoyl-rac-glycerol is a triacylglycerol containing palmitic acid (HY-N0830) at the sn-1 and sn-2 positions and linoelaidic acid (HY-W071746) at the sn-3 position. Palmitic acid is a long-chain saturated fatty acid commonly found in both animals and plants. Palmitic acid can induce the expression of glucose-regulated protein 78 (GRP78) and CCAAT/enhancer binding protein homologous protein (CHOP) in in mouse granulosa cells. Linolelaidic acid, an omega-6 trans fatty acid, acts as a source of energy. Linolelaidic acid is an essential nutrient, adding in enteral, parenteral, and infant formulas. Linolelaidic acid can be used for heart diseases research .
    12-Dipalmitoyl-3-Linoelaidoyl-rac-glycerol

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: